Avricore Health (AVCRF) Return on Capital Employed (2014 - 2025)
Avricore Health (AVCRF) reported Return on Capital Employed of 75.62% for Q3 2025, down 8036.0% year-over-year from 0.95% in Q3 2024, and down 105.36% quarter-over-quarter from 36.82% in Q2 2025.
Avricore Health (AVCRF) Return on Capital Employed (2014 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 12 years of Return on Capital Employed data on file, last reported at 75.62% in Q3 2025.
- Return on Capital Employed for Q3 2025 came in at 75.62%, down 8036.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 75.62% (down 8036.0% YoY), and the FY2025 annual result was 176.74%, down 18280.0% from the prior year.
- Return on Capital Employed retreated to 75.62% in Q3 2025 per AVCRF's latest filing, from 36.82% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 4.74% in Q3 2024 and troughed at 75.62% in Q3 2025.
- A 5-year average of 20.01% and a median of 15.88% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2024: Return on Capital Employed plunged 13109 bps in 2021, then jumped 4575 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 7.48% in 2021, then tumbled by 409 bps to 38.03% in 2022, then jumped by 50 bps to 19.09% in 2023, then jumped by 125 bps to 4.74% in 2024, then slumped by 1696 bps to 75.62% in 2025.
- Business Quant data shows AVCRF's Return on Capital Employed at 75.62% in Q3 2025, 36.82% in Q2 2025, and 1.67% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -75.62% |
| Jun 30, 2025 | -36.82% |
| Mar 31, 2025 | -1.67% |
| Sep 30, 2024 | 4.74% |
| Jun 30, 2024 | -0.27% |
| Mar 31, 2024 | -16.58% |
| Dec 31, 2023 | -19.09% |
| Sep 30, 2023 | -41.01% |
| Jun 30, 2023 | -31.35% |
| Mar 31, 2023 | -25.87% |
| Dec 31, 2022 | -38.03% |
| Sep 30, 2022 | -27.35% |
| Jun 30, 2022 | -15.17% |
| Mar 31, 2022 | -7.04% |
| Dec 31, 2021 | -7.48% |
| Sep 30, 2021 | -6.82% |
| Jun 30, 2021 | -6.38% |
| Mar 31, 2021 | -8.34% |
| Dec 31, 2020 | 12.91% |
| Sep 30, 2020 | 31.53% |